Literature DB >> 25735687

Intensive care unit admission in patients following rapid response team activation: call factors, patient characteristics and hospital outcomes.

M P Le Guen1, A E Tobin1, D Reid1.   

Abstract

Rapid Response Systems (RRSs) have been widely introduced throughout hospital health systems, yet there is limited research on the characteristics and outcomes of patients admitted to an intensive care unit (ICU) following RRS activation. Using database extraction, this study examined the factors associated with ICU admission and patient outcome in patients receiving RRS activation in a tertiary level hospital between 2009 and 2013. Of 3004 RRS activations, 392 resulted in ICU admissions. Call factors associated with ICU admission and increased hospital mortality included tachypnoea (P <0.001 and P <0.001, respectively), hypoxia (P <0.001 and P <0.001, respectively) and having multiple Medical Emergency Team call triggers breached simultaneously (P <0.001 and P <0.001, respectively). Patients with seizures (P <0.001) and tachycardia (P=0.004) were more likely to survive to hospital discharge. Patient factors associated with ICU admission included young age (P <0.001) and having severe liver disease (P <0.001). Factors associated with increased hospital mortality included delayed RRS activation (P <0.001), increased age (P <0.001) and comorbidities including ischaemic heart disease (P=0.006), congestive heart failure (P <0.001), chronic kidney disease (P <0.001) and severe liver disease (P <0.001). Multiple factors relating to both the nature of the RRS activation call and patient characteristics are associated with ICU admission and hospital mortality post RRS activation. This information may be useful for risk stratification of deteriorating patients and determination of appropriate escalation.

Entities:  

Keywords:  adult; intensive care; medical emergency team; mortality; rapid response team

Mesh:

Year:  2015        PMID: 25735687     DOI: 10.1177/0310057X1504300211

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  7 in total

1.  [Deployment of the in-hospital emergency team in a tertiary care university hospital : Data analysis for the time period 2013-2016 in North-Rhine/Westphalia].

Authors:  J Schmitz; S Kerkhoff; D Sander; G Schulz; T Warnecke; J Hinkelbein
Journal:  Anaesthesist       Date:  2019-04-10       Impact factor: 1.041

2.  Finally time for rapid response systems to be well MET in Europe?

Authors:  Markus B Skrifvars; Ignacio Martin-Loeches
Journal:  Intensive Care Med       Date:  2016-02-24       Impact factor: 17.440

Review 3.  Early warning systems and rapid response systems for the prevention of patient deterioration on acute adult hospital wards.

Authors:  Jennifer McGaughey; Dean A Fergusson; Peter Van Bogaert; Louise Rose
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

4.  Early Detection of In-Patient Deterioration: One Prediction Model Does Not Fit All.

Authors:  Jacob N Blackwell; Jessica Keim-Malpass; Matthew T Clark; Rebecca L Kowalski; Salim N Najjar; Jamieson M Bourque; Douglas E Lake; J Randall Moorman
Journal:  Crit Care Explor       Date:  2020-05-11

Review 5.  Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms-Biomarkers-Interventions, and Future Perspectives.

Authors:  Paraskevi Pavlakou; Vassilios Liakopoulos; Theodoros Eleftheriadis; Michael Mitsis; Evangelia Dounousi
Journal:  Oxid Med Cell Longev       Date:  2017-09-28       Impact factor: 6.543

6.  Determinants and outcomes associated with decisions to deny intensive care unit admission in Tunisian ICU.

Authors:  Rania Bouneb; Menel Mellouli; Maha Dardouri; Houda Ben Soltane; Imed Chouchene; Mohamed Boussarsar
Journal:  Pan Afr Med J       Date:  2018-03-26

7.  Does the Time of Solitary Rapid Response Team Call Affect Patient Outcome?

Authors:  Manoj Y Singh; Ramprasad Vegunta; Krishna Karpe; Sumeet Rai
Journal:  Indian J Crit Care Med       Date:  2020-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.